From Restoring Sight to Reimagining the Brain, with Max Hodak
Science Corp's Prima retinal prosthesis received European regulatory approval, first to restore vision in blind patients
“Nobody had previously ever been able to restore a form vision image in the mind's eye of a blind patient in this way.”
Max Hodak, CEO of Science Corp and Neuralink co-founder, discusses Prima, a retinal prosthesis that just received European regulatory approval and represents the first-ever restoration of visual imagery for blind patients. The episode also covers substrate independence for the brain and alignable representations between AI models and neuroscience. While the AI-neuroscience angle is notable, this is primarily a medtech milestone story with peripheral AI relevance.